Microorganisms for the production of insect pheromones and related compounds

Inventors: Effendi Leonard (Santa Monica, CA); Peter Meinhold (Topanga, CA); Keith Wampler (Santa Monica, CA); Pedro Coelho (Santa Monica, CA); Micah Sheppard (Santa Monica, CA); Thomas Heel (Los Angeles, CA)

Assignee: Provivi, Inc.

A01N63/50 A01N31/02 C12N9/0008 C12N9/0071 C12P7/04 C12P7/62 C12P7/6436 C12P7/6472 C12Y102/0105 C12Y114/19001 C12Y114/19005

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 11,844,353
App. No.: 17/408,050
Granted: Dec 19, 2023
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present application relates to recombinant microorganisms useful in the biosynthesis of unsaturated C 6 -C 24 fatty alcohols, aldehydes, and acetates which may be useful as insect pheromones, fragrances, flavors, and polymer intermediates. The C 6 -C 24 fatty alcohols, aldehydes, and acetates described herein may be used as substrates for metathesis reactions to expand the repertoire of target compounds and pheromones. The application further relates to recombinant microorganisms co-expressing a pheromone pathway and a pathway for the production of a toxic protein, peptide, oligonucleotide, or small molecule suitable for use in an attract-and-kill pest control approach. Also provided are methods of producing unsaturated C 6 -C 24 fatty alcohols, aldehydes, and acetates using the recombinant microorganisms, as well as compositions comprising the recombinant microorganisms and/or optionally one or more of the product alcohols, aldehydes, or acetates.

Claims (24)

1. A method of producing a mono- or poly-unsaturated C 6 -C 24 fatty acyl-CoA, comprising:

a) providing a recombinant Yarrowia lipolytica comprising a heterologous nucleic acid molecule encoding and expressing a Helicoverpa fatty acyl desaturase comprising a transmembrane desaturase sequence motif of HX 3-4 HX 7-41 (3 non-His)HX 2-3 (1 non-His)HHX 61-189 (40 non-His)HX 2-3 (1 non-His)HH; and

b) cultivating the recombinant Yarrowia lipolytica of (a) in a culture medium containing a carbon source feedstock and a saturated C 6 -C 24 fatty acyl-CoA;

wherein the saturated C 6 -C 24 fatty acyl-CoA is converted to a mono- or poly-unsaturated C 6 -C 24 fatty acyl-CoA by catalytic activity of the desaturase.

2. The method of claim 1 , wherein the Helicoverpa fatty acyl desaturase is a Z11 desaturase.

3. The method of claim 1 , wherein the mono- or poly-unsaturated C6-C24 fatty acyl-CoA is selected from the group consisting of Z11-13:Acyl-CoA, E11-13:Acyl-CoA, (Z,Z)-7,11-13:Acyl-CoA, Z11-14:Acyl-CoA, E11-14:Acyl-CoA, (E,E)-9,11-14:Acyl-CoA, (E,Z)-9,11-14:Acyl-CoA, (Z,E)-9,11-14:Acyl-CoA, (Z,Z)-9,11-14:Acyl-CoA, (E,Z)-9,11-15:Acyl-CoA, (Z,Z)-9,11-15:Acyl-CoA, Z11-16:Acyl-CoA, E11-16:Acyl-CoA, (E,Z)-6,11-16:Acyl-CoA, (E,Z)-7,11-16:Acyl-CoA, (E,Z)-8,11-16:Acyl-CoA, (E,E)-9,11-16:Acyl-CoA, (E,Z)-9,11-16:Acyl-CoA, (Z,E)-9,11-16:Acyl-CoA, (Z,Z)-9,11-16:Acyl-CoA, (E,E)-11,13-16:Acyl-CoA, (E,Z)-11,13-16:Acyl-CoA, (Z,E)-11,13-16:Acyl-CoA, (Z,Z)-11,13-16:Acyl-CoA, (Z,E)-11,14-16:Acyl-CoA, (E,E,Z)-4,6,11-16:Acyl-CoA, (Z,Z,E)-7,11,13-16:Acyl-CoA, (E,E,Z,Z)-4,6,11,13-16:Acyl-CoA, Z11-17:Acyl-CoA, (Z,Z)-8,11-17:Acyl-CoA, Z11-18:Acyl-CoA, E11-18:Acyl-CoA, (Z,Z)-11,13-18:AcylCoA, (E,E)-11, 14-18:Acyl-CoA, and combinations thereof.

4. The method of claim 1 , wherein the mono- or poly-unsaturated C6-C24 fatty acyl-CoA is selected from the group consisting of Z9-11:Acyl-CoA, Z9-12:Acyl-CoA, E9-12:Acyl-CoA, (E,E)-7,9-12:Acyl-CoA, (E,Z)-7,9-12:Acyl-CoA, (Z,E)-7,9-12:Acyl-CoA, (Z,Z)-7,9-12:Acyl-CoA, Z9-13:Acyl-CoA, E9-13:Acyl-CoA, (E,Z)-5,9-13:Acyl-CoA, (Z,E)-5,9-13:Acyl-CoA, (Z,Z)-5,9-13:Acyl-CoA, Z9-14:Acyl-CoA, E9-14:Acyl-CoA, (E,Z)-4,9-14:Acyl-CoA, (E,E)-9,11-14:Acyl-CoA, (E,Z)-9, 11-14:Acyl-CoA, (Z,E)-9, 11-14:Acyl-CoA, (Z,Z)-9,11-14:Acyl-CoA, (E,E)-9,12-14:Acyl-CoA, (Z,E)-9,12-14:AcylCoA, (Z,Z)-9,12-14:Acyl-CoA, Z9-15:Acyl-CoA, E9-15:Acyl-CoA, (Z,Z)-6,9-15:AcylCoA, Z9-16:Acyl-CoA, E9-16:Acyl-CoA, (E,E)-9,11-16:Acyl-CoA, (E,Z)-9,11-16:AcylCoA, (Z,E)-9,11-16:Acyl-CoA, (Z,Z)-9,11-16:Acyl-CoA, Z9-17:Acyl-CoA, E9-18:AcylCoA, Z9-18:Acyl-CoA, (E,E)-5,9-18:Acyl-CoA, (E,E)-9,12-18:Acyl-CoA, (Z,Z)-9,12-18:Acyl-CoA, (Z,Z,Z)-3,6,9-18:Acyl-CoA, (E,E,E)-9,12,15-18:Acyl-CoA, (Z,Z,Z)-9,12,15-18:Acyl-CoA, and combinations thereof.

5. The method of claim 1 , wherein the recombinant Yarrowia lipolytica comprises a second heterologous nucleic acid molecule encoding and expressing a fatty alcohol forming fatty-acyl reductase that converts the mono- or poly-unsaturated C6-C24 fatty acyl-CoA into a corresponding mono- or poly-unsaturated C6-C24 fatty alcohol.

6. The method of claim 5 , further comprising metathesizing the mono- or poly-unsaturated C6-C24 fatty alcohol with an unsaturated C3-C10 hydrocarbon, thereby forming an elongated mono- or polyunsaturated C6-C24 fatty alcohol, or a truncated mono- or polyunsaturated C6-C24 fatty alcohol.

7. The method of claim 5 , wherein the mono- or poly-unsaturated C6-C24 fatty alcohol is selected from the group consisting of (Z)-3-hexen-1-ol, (Z)-3-nonen-1-ol, (E)-2-decen-1-ol, (Z)-2-decen-1-ol, (E)-3-decen-1-ol, (Z)-3-decen-1-ol, (Z)-4-decen-1-ol, (E)-5-decen-1-ol, (Z)-5-decen-1-ol, (E)-8-decen-1-ol, (Z,Z)-4,7-decadien-1-ol, (Z)-3-dodecen-1-ol, (E)-5-dodecen-1-ol, (Z)-5-dodecen-1-ol, (E)-6-dodecen-1-ol, (E)-7-dodecen-1-ol, (Z)-7-dodecen-1-ol, (E)-8-dodecen-1-ol, (Z)-8-dodecen-1-ol, (E)-9-dodecen-1-ol, (Z)-9-dodecen-1-ol, (E)-10-dodecen-1-ol, (Z)-10-dodecen-1-ol, (Z,Z)-3,6-dodecadien-1-ol, (E,E)-5,7-dodecadien-1-ol, (E,Z)-5,7-dodecadien-1-ol, (Z,E)-5,7-dodecadien-1-ol, (E,Z)-7,9-dodecadien-1-ol, (Z,E)-7,9-dodecadien-1-ol, (Z,Z)-7,9-dodecadien-1-ol, (E,E)-8,10-dodecadien-1-ol, (E,Z)-8,10-dodecadien-1-ol, (Z,E)-8,10-dodecadien-1-ol, (Z,Z)-8,10-dodecadien-1-ol, (Z,E,E)-3,6,8-dodecatrien-1-ol, (Z,Z,E)-3,6,8-dodecatrien-1-ol, (Z,Z)-4,7-tridecadien-1-ol, (E)-3-tetradecen-1-ol, (Z)-3-tetradecen-1-ol, (E)-5-tetradecen-1-ol, (Z)-5-tetradecen-1-ol, (E)-7-tetradecen-1-ol, (Z)-7-tetradecen-1-ol, (Z)-8-tetradecen-1-ol, (E)-9-tetradecen-1-ol, (Z)-9-tetradecen-1-ol, (E)-11-tetradecen-1-ol, (Z)-11-tetradecen-1-ol, (Z,Z)-5,8-tetradecadien-1-ol, (E,E)-8,10-tetradecadien-1-ol, (Z,E)-8,10-tetradecadien-1-ol, (Z,E)-9,11-tetradecadien-1-ol, (Z,Z)-9,11-tetradecadien-1-ol, (Z,E)-9,12-tetradecadien-1-ol, (Z,Z)-9,12-tetradecadien-1-ol, (E,E)-10,12-tetradecadien-1-ol, (Z,Z)-10,12-tetradecadien-1-ol, (E)-8-pentadecen-1-ol, (Z)-8-pentadecen-1-ol, (Z,Z)-6,9-pentadecadien-1-ol, (E,Z)-8,10-pentadecadien-1-ol, (E)-5-hexadecen-1-ol, (Z)-5-hexadecen-1-ol, (E)-7-hexadecen-1-ol, (Z)-7-hexadecen-1-ol, (E)-9-hexadecen-1-ol, (Z)-9-hexadecen-1-ol, (E)-10-hexadecen-1-ol, (E)-11-hexadecen-1-ol, (Z)-11-hexadecen-1-ol, (E,E)-1,3-hexadecadien-1-ol, (E,Z)-4,6-hexadecadien-1-ol, (Z,Z)-7,10-hexadecadien-1-ol, (Z,E)-7,11-hexadecadien-1-ol, (Z,Z)-7,11-hexadecadien-1-ol, (E,E)-10,12-hexadecadien-1-ol, (E,Z)-10,12-hexadecadien-1-ol, (E,E)-11,13-hexadecadien-1-ol, (E,Z)-11,13-hexadecadien-1-ol, (Z,E)-11,13-hexadecadien-1-ol, (Z,Z)-11,13-hexadecadien-1-ol, (E,E,Z)-4,6,10-hexadecatrien-1-ol, (E,Z,Z)-4,6,10-hexadecatrien-1-ol, (E)-8-heptadecen-1-ol, (Z)-8-heptadecen-1-ol, (Z)-11-heptadecen-1-ol, (Z,Z)-8,10-heptadecadien-1-ol, (E)-9-octadecen-1-ol, (Z)-9-octadecen-1-ol, (E)-11-octadecen-1-ol, (Z)-11-octadecen-1-ol, (Z)-13-octadecen-1-ol, (E,Z)-2,13-octadecadien-1-ol, (Z,Z)-2,13-octadecadien-1-ol, (E,E)-5,9-octadecadien-1-ol, (E,E)-9,12-octadecadien-1-ol, (E,E,E)-9,12,15-octadecatrien-1-ol, and combinations thereof.

8. The method of claim 5 , wherein the recombinant microorganism further comprises at least one endogenous or exogenous nucleic acid molecule encoding an acetyl transferase that converts the C6-C24 fatty alcohol into a corresponding C5-C24 fatty acetate.

9. The method of claim 8 , further comprising metathesizing the mono- or poly-unsaturated C6-C24 fatty acetate with an unsaturated C3-C10 hydrocarbon, thereby forming an elongated mono- or polyunsaturated C6-C24 fatty acetate, or a truncated mono- or polyunsaturated C6-C24 fatty acetate.

10. The method of claim 8 , wherein the mono- or polyunsaturated C6-C24 fatty acetate is an insect pheromone.

11. The method of claim 8 , wherein the mono- or polyunsaturated C6-C24 fatty acetate is selected from the group consisting of (E)-2-decenyl acetate, (Z)-2-decenyl acetate, (Z)-3-decenyl acetate, (E)-4-decenyl acetate, (Z)-4-decenyl acetate, (E)-5-decenyl acetate, (Z)-5-decenyl acetate, (E)-7-decenyl acetate, (Z)-7-decenyl acetate, (E,E)-3,5-decadienyl acetate, (Z,E)-3,5-decadienyl acetate, (Z,Z)-4,7-decadienyl acetate, (E)-2-undecenyl acetate, (Z)-5-undecenyl acetate, (Z)-7-undecenyl acetate, (Z)-8-undecenyl acetate, (Z)-9-undecenyl acetate, (E)-3-dodecenyl acetate, (Z)-3-dodecenyl acetate, (E)-4-dodecenyl acetate, (E)-5-dodecenyl acetate, (Z)-5-dodecenyl acetate, (Z)-6-dodecenyl acetate, (E)-7-dodecenyl acetate, (Z)-7-dodecenyl acetate, (E)-8-dodecenyl acetate, (Z)-8-dodecenyl acetate, (E)-9-dodecenyl acetate, (Z)-9-dodecenyl acetate, (E)-10-dodecenyl acetate, (Z)-10-dodecenyl acetate, (E,Z)-3,5-dodecadienyl acetate, (Z,E)-3,5-dodecadienyl acetate, (E,E)-4,10-dodecadienyl acetate, (E,E)-5,7-dodecadienyl acetate, (E,Z)-5,7-dodecadienyl acetate, (Z,E)-5,7-dodecadienyl acetate, (Z,Z)-5,7-dodecadienyl acetate, (E,E)-7,9-dodecadienyl acetate, (E,Z)-7,9-dodecadienyl acetate, (Z,E)-7,9-dodecadienyl acetate, (Z,Z)-7,9-dodecadienyl acetate, (E,E)-8,10-dodecadienyl acetate, (E,Z)-8,10-dodecadienyl acetate, (Z,E)-8,10-dodecadienyl acetate, (Z,Z)-8,10-dodecadienyl acetate, (E)-2-tridecenyl acetate, (Z)-2-tridecenyl acetate, (E)-3-tridecenyl acetate, (E)-4-tridecenyl acetate, (Z)-4-tridecenyl acetate, (E)-6-tridecenyl acetate, (Z)-7-tridecenyl acetate, (E)-8-tridecenyl acetate, (Z)-8-tridecenyl acetate, (E)-9-tridecenyl acetate, (Z)-9-tridecenyl acetate, (Z)-10-tridecenyl acetate, (E)-11-tridecenyl acetate, (Z)-11-tridecenyl acetate, (E,Z)-4,7-tridecadienyl acetate, (Z,Z)-4,7-tridecadienyl acetate, (E,Z)-5,9-tridecadienyl acetate, (Z,E)-5,9-tridecadienyl acetate, (Z,Z)-5,9-tridecadienyl acetate, (Z,Z)-7,11-tridecadienyl acetate, (E,Z,Z)-4,7,10-tridecatrienyl acetate, (E)-3-tetradecenyl acetate, (Z)-3-tetradecenyl acetate, (E)-5-tetradecenyl acetate, (Z)-5-tetradecenyl acetate, (E)-6-tetradecenyl acetate, (Z)-6-tetradecenyl acetate, (E)-7-tetradecenyl acetate, (Z)-7-tetradecenyl acetate, (E)-8-tetradecenyl acetate, (Z)-8-tetradecenyl acetate, (E)-9-tetradecenyl acetate, (Z)-9-tetradecenyl acetate, (E)-10-tetradecenyl acetate, (Z)-10-tetradecenyl acetate, (E)-11-tetradecenyl acetate, (Z)-11-tetradecenyl acetate, (E)-12-tetradecenyl acetate, (Z)-12-tetradecenyl acetate, (E,E)-3,5-tetradecadienyl acetate, (E,Z)-3,5-tetradecadienyl acetate, (Z,E)-3,5-tetradecadienyl acetate, (E,Z)-3,7-tetradecadienyl acetate, (E,Z)-3,8-tetradecadienyl acetate, (E,Z)-4,9-tetradecadienyl acetate, (E,Z)-4,10-tetradecadienyl acetate, (Z,Z)-5,8-tetradecadienyl acetate, (E,E)-8,10-tetradecadienyl acetate, (E,Z)-8,10-tetradecadienyl acetate, (Z,E)-8,10-tetradecadienyl acetate, (E,E)-9,11-tetradecadienyl acetate, (E,Z)-9,11-tetradecadienyl acetate, (Z,E)-9,11-tetradecadienyl acetate, (Z,Z)-9,11-tetradecadienyl acetate, (E,E)-9,12-tetradecadienyl acetate, (Z,E)-9,12-tetradecadienyl acetate, (Z,Z)-9,12-tetradecadienyl acetate, (E,E)-10,12-tetradecadienyl acetate, (E,Z)-10,12-tetradecadienyl acetate, (Z,E)-10,12-tetradecadienyl acetate, (Z,Z)-10,12-tetradecadienyl acetate, (E,Z,Z)-3,8,11-tetradecatrienyl acetate, (E)-8-pentadecenyl acetate, (Z)-8-pentadecenyl acetate, (Z)-9-pentadecenyl acetate, (E)-9-pentadecenyl acetate, (Z)-10-pentadecenyl acetate, (E)-12-pentadecenyl acetate, (Z)-12-pentadecenyl acetate, (Z,Z)-6,9-pentadecadienyl acetate, (E,E)-8,10-pentadecadienyl acetate, (E,Z)-8,10-pentadecadienyl acetate, (Z,E)-8,10-pentadecadienyl acetate, (Z,Z)-8,10-pentadecadienyl acetate, (Z)-3-hexadecenyl acetate, (E)-5-hexadecenyl acetate, (Z)-5-hexadecenyl acetate, (E)-6-hexadecenyl acetate, (E)-7-hexadecenyl acetate, (Z)-7-hexadecenyl acetate, (E)-8-hexadecenyl acetate, (E)-9-hexadecenyl acetate, (Z)-9-hexadecenyl acetate, (Z)-10-hexadecenyl acetate, (E)-11-hexadecenyl acetate, (Z)-11-hexadecenyl acetate, (Z)-12-hexadecenyl acetate, (Z)-14-hexadecenyl acetate, (E,Z)-4,6-hexadecadienyl acetate, (E,Z)-6,11-hexadecadienyl acetate, (Z,Z)-7,10-hexadecadienyl acetate, (Z,E)-7,11-hexadecadienyl acetate, (Z,Z)-7,11-hexadecadienyl acetate, (Z,Z)-8,10-hexadecadienyl acetate, (E,Z)-9,11-hexadecadienyl acetate, (E,E)-10,12-hexadecadienyl acetate, (E,Z)-10,12-hexadecadienyl acetate, (Z,E)-10,12-hexadecadienyl acetate, (E,E)-11,13-hexadecadienyl acetate, (E,Z)-11,13-hexadecadienyl acetate, (Z,E)-11,13-hexadecadienyl acetate, (Z,Z)-11,13-hexadecadienyl acetate, (Z,E)-11,14-hexadecadienyl acetate, (E,E,Z)-4,6,10-hexadecatrienyl acetate, (E,Z,Z)-4,6,10-hexadecatrienyl acetate, (E,E,Z)-4,6,11-hexadecatrienyl acetate, (E,E,E)-10,12,14-hexadecatrienyl acetate, (E,E,Z)-10,12,14-hexadecatrienyl acetate, (E)-8-heptadecenyl acetate, (E)-10-heptadecenyl acetate, (Z)-11-heptadecenyl acetate, (E,E)-4,8-heptadecadienyl acetate, (Z,Z)-8,11-heptadecadienyl acetate, (E)-2-octadecenyl acetate, (Z)-2-octadecenyl acetate, (E)-9-octadecenyl acetate, (Z)-9-octadecenyl acetate, (Z)-11-octadecenyl acetate, (E)-13-octadecenyl acetate, (Z)-13-octadecenyl acetate, (E,Z)-2,13-octadecadienyl acetate, (Z,E)-2,13-octadecadienyl acetate, (Z,Z)-2,13-octadecadienyl acetate, (E,E)-3,13-octadecadienyl acetate, (E,Z)-3,13-octadecadienyl acetate, (Z,E)-3,13-octadecadienyl acetate, (Z,Z)-3,13-octadecadienyl acetate, (E,E)-5,9-octadecadienyl acetate, (Z,Z)-9,12-octadecadienyl acetate, (Z,Z,Z)-3,6,9-octadecatrienyl acetate, (Z,Z,Z)-9,12,15-octadecatrienyl acetate, and combinations thereof.

12. The method of claim 1 , wherein the recombinant Yarrowia lipolytica comprises a second heterologous nucleic acid molecule encoding and expressing a fatty aldehyde forming fatty-acyl reductase that converts the mono- or poly-unsaturated C6-C24 fatty acyl-CoA to a corresponding mono- or poly-unsaturated C6-C24 fatty aldehyde.

13. The method of claim 12 , further comprising metathesizing the mono- or poly-unsaturated C6-C24 fatty aldehyde with an unsaturated C3-C10 hydrocarbon, thereby forming an elongated mono- or polyunsaturated C6-C24 fatty aldehyde, or a truncated mono- or polyunsaturated C6-C24 fatty aldehyde.

14. The method of claim 12 , wherein the mono- or polyunsaturated C6-C24 fatty aldehyde is an insect pheromone.

15. The method of claim 12 , wherein the mono- or poly-unsaturated C6-C24 fatty aldehyde is selected from the group consisting of (E)-2-decenal, (Z)-2-decenal, (Z)-4-decenal, (Z)-5-decenal, (E,E)-2,4-decadienal, (E,Z)-2,4-decadienal, (Z,Z)-2,4-decadienal, (E)-2-undecenal, (E)-2-dodecenal, (Z)-5-dodecenal, (E)-6-dodecenal, (E)-7-dodecenal, (Z)-7-dodecenal, (E)-8-dodecenal, (E)-9-dodecenal, (Z)-9-dodecenal, (E)-10-dodecenal, (E,Z)-5,7-dodecadienal, (Z,E)-5,7-dodecadienal, (Z,Z)-5,7-dodecadienal, (E,Z)-7,9-dodecadienal, (E,E)-8,10-dodecadienal, (E,Z)-8,10-dodecadienal, (Z,E)-8,10-dodecadienal, (Z)-4-tridecenal, (E)-5-tetradecenal, (Z)-5-tetradecenal, (Z)-7-tetradecenal, (Z)-8-tetradecenal, (Z)-9-tetradecenal, (E)-11-tetradecen al, (Z)-11-tetradecenal, (E,E)-2,4-tetradecadienal, (E,Z)-4,9-tetradecadienal, (E,E)-5,8-tetradecadienal, (Z,Z)-5,8-tetradecadienal, (E,E)-8,10-tetradecadienal, (E,Z)-8,10-tetradecadienal, (Z,Z)-8,10-tetradecadienal, (Z,E)-9,11-tetradecadienal, (Z,Z)-9,11-tetradecadienal, (Z,E)-9,12-tetradecadienal, (E,E)-10,12-tetradecadienal, (Z)-10-pentadecenal, (Z,Z)-6,9-pentadecadienal, (E,Z)-9,11-pentadecadienal, (Z,Z)-9,11-pentadecadienal, (E)-7-hexadecenal, (Z)-7-hexadecenal, (E)-9-hexadecenal, (Z)-9-hexadecenal, (E)-10-hexadecenal, (Z)-10-hexadecenal, (E)-11-hexadecenal, (Z)-11-hexadecenal, (Z)-12-hexadecenal, (E)-14-hexadecenal, (E,Z)-4,6-hexadecadienal, (E,Z)-6,11-hexadecadienal, (Z,E)-7,11-hexadecadienal, (Z,Z)-7,11-hexadecadienal, (E,Z)-8,11-hexadecadienal, (E,E)-9,11-hexadecadienal, (E,Z)-9,11-hexadecadienal, (Z,E)-9,11-hexadecadienal, (Z,Z)-9,11-hexadecadienal, (E,E)-10,12-hexadecadienal, (E,Z)-10,12-hexadecadienal, (Z,E)-10,12-hexadecadienal, (Z,Z)-10,12-hexadecadienal, (E,E)-11,13-hexadecadienal, (E,Z)-11,13-hexadecadienal, (Z,E)-11,13-hexadecadienal, (Z,Z)-11,13-hexadecadienal, (E,E)-10,14-hexadecadienal, (E,E,Z)-4,6,11-hexadecatrienal, (Z,Z,E)-7,11,13-hexadecatrienal, (E,E,E)-10,12,14-hexadecatrienal, (E,E,Z)-10,12,14-hexadecatrienal, (E,E,Z,Z)-4,6,11,13-hexadecatetraenal, (E)-2-heptadecenal, (Z)-2-heptadecenal, (Z)-9-heptadecenal, (E)-2-octadecenal, (Z)-2-octadecenal, (E)-9-octadecenal, (Z)-9-octadecenal, (E)-11-octadecenal, (Z)-11-octadecenal, (E)-13-octadecenal, (Z)-13-octadecenal, (E)-14-octadecenal, (E,Z)-2,13-octadecadienal, (E,Z)-3,13-octadecadienal, (Z,Z)-3,13-octadecadienal, (Z,Z)-9,12-octadecadienal, (Z,Z)-11,13-octadecadienal, (E,E)-11,14-octadecadienal, (Z,Z)-13,15-octadecadienal, (Z,Z,Z)-9,12,15-octadecatrienal, and combinations thereof.

16. The method of claim 1 , wherein the heterologous nucleic acid molecule comprises a nucleotide sequence encoding the amino acid sequence encoded by SEQ ID NO: 39.

17. The method of claim 1 , comprising a disruption of the fao1 gene.

18. The method of claim 1 , comprising a disruption in a gene selected from the group consisting of the pox1, pox2, pox3, pox4, pox5, pox6, and combinations thereof.

19. The method of claim 1 , comprising a disruption in a gene selected from the group consisting of the adh1, adh2, adh3, adh4, adh5, adh6, adh7, and combinations thereof.

20. The method of claim 1 , wherein the heterologous nucleic acid molecule comprises a nucleotide sequence encoding an amino acid sequence having at least 80% identity to the amino acid sequence encoded by SEQ ID NO: 27.

21. The method of claim 1 , wherein the heterologous nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO: 27.

Assignments (2)

SECURITY INTEREST Recorded Aug 24, 2023

From: PROVIVI, INC.

To: HORIZON TECHNOLOGY FINANCE CORPORATION

Reel/Frame 064697/0700 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2021

From: LEONARD, EFFENDI; MEINHOLD, PETER; WAMPLER, KEITH; COELHO, PEDRO; SHEPPARD, MICAH; HEEL, THOMAS

To: PROVIVI, INC.

Reel/Frame 057484/0599 →